作者: Henry L. Hudson
DOI: 10.1007/978-1-59745-449-0_17
关键词: Depression (differential diagnoses) 、 Visual impairment 、 Macular degeneration 、 Medicine 、 Choroidal neovascularization 、 Activities of daily living 、 Ophthalmology 、 Central scotoma 、 Macular scar 、 Quality of life
摘要: Age-related macular degeneration (AMD) is the leading cause of blindness in United States and has a significant impact on public health (1). Almost 1.8 million people have advanced AMD, which defined as choroidal neovascularization (CNV) or geographic atrophy that results scarring visual loss central field (2,3). The stages AMD can be considered “end-stage” when result bilateral, untreatable scars causing scotomata associated moderate to profound impairment limits patient’s ability engage daily activities requiring good vision. Advanced forms are with legal blindness, elevated risk depression, reduced independence, increased accidents, decrease quality life (4, 5, 6).